• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

天然多酚化合物对 SARS-CoV-2 的蛋白酶抑制作用:一项计算机研究。

Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study.

机构信息

National Institute of Pharmaceutical Education and Research, Kolkata 70054, India.

Institute for Bioinformatics and Medical Informatics, University of Tübingen, Sand 14, 72076 Tübingen, Germany.

出版信息

Molecules. 2020 Oct 10;25(20):4604. doi: 10.3390/molecules25204604.

DOI:10.3390/molecules25204604
PMID:33050360
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7587198/
Abstract

The current pandemic, caused by SARS-CoV-2 virus, is a severe challenge for human health and the world economy. There is an urgent need for development of drugs that can manage this pandemic, as it has already infected 19 million people and led to the death of around 711,277 people worldwide. At this time, in-silico studies are providing lots of preliminary data about potential drugs, which can be a great help in further in-vitro and in-vivo studies. Here, we have selected three polyphenolic compounds, mangiferin, glucogallin, and phlorizin. These compounds are isolated from different natural sources but share structural similarities and have been reported for their antiviral activity. The objective of this study is to analyze and predict the anti-protease activity of these compounds on SARS-CoV-2main protease (Mpro) and TMPRSS2 protein. Both the viral protein and the host protein play an important role in the viral life cycle, such as post-translational modification and viral spike protein priming. This study has been performed by molecular docking of the compounds using PyRx with AutoDock Vina on the two aforementioned targets chosen for this study, i.e., SARS-CoV-2 Mpro and TMPRSS2. The compounds showed good binding affinity and are further analyzed by (Molecular dynamic) MD and Molecular Mechanics Poisson-Boltzmann Surface Area MM-PBSA study. The MD-simulation study has predicted that these natural compounds will have a great impact on the stabilization of the binding cavity of the Mpro of SARS-CoV-2. The predicted pharmacokinetic parameters also show that these compounds are expected to have good solubility and absorption properties. Further predictions for these compounds also showed no involvement in drug-drug interaction and no toxicity.

摘要

当前由 SARS-CoV-2 病毒引起的大流行对人类健康和世界经济构成了严重挑战。迫切需要开发能够应对这种大流行的药物,因为它已经感染了 1900 万人,并导致全球约 711277 人死亡。此时,计算机模拟研究为潜在药物提供了大量初步数据,这对进一步的体外和体内研究将有很大帮助。在这里,我们选择了三种多酚类化合物,芒果苷、葡萄糖醛酸和根皮苷。这些化合物分别从不同的天然来源中分离出来,但具有结构相似性,并已被报道具有抗病毒活性。本研究旨在分析和预测这些化合物对 SARS-CoV-2 主要蛋白酶(Mpro)和 TMPRSS2 蛋白的抗蛋白酶活性。病毒蛋白和宿主蛋白在病毒生命周期中都起着重要作用,如翻译后修饰和病毒刺突蛋白的启动。这项研究是通过使用 PyRx 与 AutoDock Vina 对这两种选择的研究靶点,即 SARS-CoV-2 Mpro 和 TMPRSS2 上的化合物进行分子对接来完成的。这些化合物显示出良好的结合亲和力,并通过(分子动态)MD 和分子力学泊松-玻尔兹曼表面积 MM-PBSA 研究进一步分析。MD 模拟研究预测,这些天然化合物将对 SARS-CoV-2 Mpro 的结合腔的稳定性产生重大影响。预测的药代动力学参数还表明,这些化合物有望具有良好的溶解度和吸收特性。对这些化合物的进一步预测还表明它们不会参与药物相互作用,也没有毒性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/d3483a521113/molecules-25-04604-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/fa66cad472b6/molecules-25-04604-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/8d3bf6eda4fd/molecules-25-04604-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/1d1feca18336/molecules-25-04604-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/7ecaaa529316/molecules-25-04604-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/56a515cad100/molecules-25-04604-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/70e085b54554/molecules-25-04604-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/d3483a521113/molecules-25-04604-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/fa66cad472b6/molecules-25-04604-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/8d3bf6eda4fd/molecules-25-04604-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/1d1feca18336/molecules-25-04604-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/7ecaaa529316/molecules-25-04604-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/56a515cad100/molecules-25-04604-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/70e085b54554/molecules-25-04604-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b4b/7587198/d3483a521113/molecules-25-04604-g007.jpg

相似文献

1
Protease Inhibitory Effect of Natural Polyphenolic Compounds on SARS-CoV-2: An In Silico Study.天然多酚化合物对 SARS-CoV-2 的蛋白酶抑制作用:一项计算机研究。
Molecules. 2020 Oct 10;25(20):4604. doi: 10.3390/molecules25204604.
2
Optimization Rules for SARS-CoV-2 M Antivirals: Ensemble Docking and Exploration of the Coronavirus Protease Active Site.SARS-CoV-2 M 抗病毒药物的优化规则:冠状病毒蛋白酶活性位点的整体对接和探索。
Viruses. 2020 Aug 26;12(9):942. doi: 10.3390/v12090942.
3
In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.新型 SARS-CoV-2 病毒主要蛋白酶的批准蛋白酶抑制剂的有效性的计算机评估。
Molecules. 2020 May 29;25(11):2529. doi: 10.3390/molecules25112529.
4
Fast Identification of Possible Drug Treatment of Coronavirus Disease-19 (COVID-19) through Computational Drug Repurposing Study.通过计算药物再利用研究快速鉴定可能用于治疗冠状病毒病 19(COVID-19)的药物。
J Chem Inf Model. 2020 Jun 22;60(6):3277-3286. doi: 10.1021/acs.jcim.0c00179. Epub 2020 May 4.
5
In Silico Insights into the SARS CoV-2 Main Protease Suggest NADH Endogenous Defences in the Control of the Pandemic Coronavirus Infection.计算机模拟揭示 SARS-CoV-2 主要蛋白酶,提示 NADH 内源性防御在控制大流行冠状病毒感染中的作用。
Viruses. 2020 Jul 26;12(8):805. doi: 10.3390/v12080805.
6
Unravelling lead antiviral phytochemicals for the inhibition of SARS-CoV-2 M enzyme through in silico approach.通过计算机模拟方法揭示抗 SARS-CoV-2 M 酶的具有抗病毒作用的植物化学成分
Life Sci. 2020 Aug 15;255:117831. doi: 10.1016/j.lfs.2020.117831. Epub 2020 May 22.
7
Drug Repurposing for Candidate SARS-CoV-2 Main Protease Inhibitors by a Novel Method.通过一种新方法对候选 SARS-CoV-2 主蛋白酶抑制剂进行药物再利用。
Molecules. 2020 Aug 23;25(17):3830. doi: 10.3390/molecules25173830.
8
Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening.SARS-CoV-2 3CLpro 的结构稳定性和通过实验筛选鉴定槲皮素为抑制剂。
Int J Biol Macromol. 2020 Dec 1;164:1693-1703. doi: 10.1016/j.ijbiomac.2020.07.235. Epub 2020 Aug 1.
9
In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.基于药物再利用的分子对接和动力学模拟预测 SARS-CoV-2 主要蛋白酶的潜在抑制剂的计算机预测。
J Infect Public Health. 2020 Sep;13(9):1210-1223. doi: 10.1016/j.jiph.2020.06.016. Epub 2020 Jun 16.
10
Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy.靶向冠状病毒主蛋白酶的二聚化:一种有潜力的广谱治疗策略。
ACS Comb Sci. 2020 Jun 8;22(6):297-305. doi: 10.1021/acscombsci.0c00058. Epub 2020 May 27.

引用本文的文献

1
Immune-Boosting and Antiviral Effects of Antioxidants in COVID-19 Pneumonia: A Therapeutic Perspective.抗氧化剂在新冠肺炎肺炎中的免疫增强和抗病毒作用:治疗视角
Life (Basel). 2025 Jan 16;15(1):113. doi: 10.3390/life15010113.
2
Jinhua Qinggan Granule UHPLC-Q-extractive-Orbitrap-MS assay: Putative identification of 45 potential anti-Covid-19 constituents, confidential addition, and pharmacopoeia quality-markers recommendation.金花清感颗粒超高效液相色谱-四级杆-静电场轨道阱高分辨质谱分析:45种潜在抗新冠病毒成分的推定鉴定、补充机密信息及药典质量标志物推荐
J Food Drug Anal. 2023 Aug 31;31(3):534-551. doi: 10.38212/2224-6614.3466.
3

本文引用的文献

1
Natural products' role against COVID-19.天然产物在抗击新冠病毒中的作用。
RSC Adv. 2020 Jun 19;10(39):23379-23393. doi: 10.1039/d0ra03774e. eCollection 2020 Jun 16.
2
Screening of plant-based natural compounds as a potential COVID-19 main protease inhibitor: an docking and molecular dynamics simulation approach.基于对接和分子动力学模拟方法筛选植物源天然化合物作为潜在的 COVID-19 主蛋白酶抑制剂。
J Biomol Struct Dyn. 2022 Feb;40(2):696-711. doi: 10.1080/07391102.2020.1817787. Epub 2020 Sep 8.
3
Drug-induced Liver Injury in a Patient With Coronavirus Disease 2019: Potential Interaction of Remdesivir With P-Glycoprotein Inhibitors.
3-Chymotrypsin-like Protease (3CLpro) of SARS-CoV-2: Validation as a Molecular Target, Proposal of a Novel Catalytic Mechanism, and Inhibitors in Preclinical and Clinical Trials.
新型冠状病毒 3- 糜蛋白酶样蛋白酶(3CLpro):作为分子靶标的验证、新型催化机制的提出以及临床前和临床试验中的抑制剂。
Viruses. 2024 May 24;16(6):844. doi: 10.3390/v16060844.
4
Hydroxy-xanthones as promising antiviral agents: Synthesis and biological evaluation against human coronavirus OC43.羟基呫吨酮类化合物作为有前途的抗病毒药物:针对人冠状病毒 OC43 的合成与生物评价。
Bioorg Med Chem Lett. 2023 Mar 15;84:129211. doi: 10.1016/j.bmcl.2023.129211. Epub 2023 Feb 28.
5
Molecular Mechanism and Role of Japanese Encephalitis Virus Infection in Central Nervous System-Mediated Diseases.日本脑炎病毒感染在中枢神经系统介导疾病中的分子机制和作用。
Viruses. 2022 Nov 30;14(12):2686. doi: 10.3390/v14122686.
6
Glucogallin Attenuates the LPS-Induced Signaling in Macrophages and Protects Mice against Sepsis.葡糖醛酸姜黄素减轻脂多糖诱导的巨噬细胞信号转导并保护小鼠免受败血症的影响。
Int J Mol Sci. 2022 Sep 24;23(19):11254. doi: 10.3390/ijms231911254.
7
studies of natural product-like caffeine derivatives as potential MAO-B inhibitors/AAR antagonists for the treatment of Parkinson's disease.作为潜在的 MAO-B 抑制剂/ AAR 拮抗剂,对天然产物样咖啡因衍生物进行研究,以治疗帕金森病。
J Integr Bioinform. 2022 Sep 19;19(4). doi: 10.1515/jib-2021-0027. eCollection 2022 Dec 1.
8
Glucogallin Attenuates RAW 264.7 Cells from Arsenic Trioxide Induced Toxicity via the NF-ҡB/NLRP3 Pathway.葡糖醛酸gallin 减轻 RAW 264.7 细胞砷三氧化二诱导的毒性通过 NF-ҡB/NLRP3 通路。
Molecules. 2022 Aug 18;27(16):5263. doi: 10.3390/molecules27165263.
9
An insight into SARS-CoV-2 structure, pathogenesis, target hunting for drug development and vaccine initiatives.对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的结构、发病机制、药物研发靶点探寻及疫苗研发进展的深入了解
RSC Med Chem. 2022 Jan 25;13(6):647-675. doi: 10.1039/d2md00009a. eCollection 2022 Jun 22.
10
In Silico Analysis of the Apoptotic and HPV Inhibitory Roles of Some Selected Phytochemicals Detected from the Rhizomes of Greater Cardamom.从大豆蔻根茎中检测到的一些植物化学成分的凋亡和 HPV 抑制作用的计算机分析
Appl Biochem Biotechnol. 2022 Oct;194(10):4867-4891. doi: 10.1007/s12010-022-04006-3. Epub 2022 Jun 7.
新型冠状病毒疾病 2019 患者的药物性肝损伤:瑞德西韦与 P-糖蛋白抑制剂的潜在相互作用。
Clin Infect Dis. 2021 Apr 8;72(7):1256-1258. doi: 10.1093/cid/ciaa883.
4
Drug repurposing against SARS-CoV-2 using E-pharmacophore based virtual screening, molecular docking and molecular dynamics with main protease as the target.基于电药效团的虚拟筛选、分子对接和分子动力学方法,针对主要蛋白酶靶点,对 SARS-CoV-2 进行药物重定位。
J Biomol Struct Dyn. 2021 Aug;39(13):4647-4658. doi: 10.1080/07391102.2020.1779819. Epub 2020 Jun 22.
5
Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors - an docking and molecular dynamics simulation study.评估绿茶多酚作为新型冠状病毒(SARS-CoV-2)主蛋白酶(Mpro)抑制剂的研究 - 对接和分子动力学模拟。
J Biomol Struct Dyn. 2021 Aug;39(12):4362-4374. doi: 10.1080/07391102.2020.1779818. Epub 2020 Jun 22.
6
Potential of Flavonoid-Inspired Phytomedicines against COVID-19.黄酮类化合物启发的植物药治疗 COVID-19 的潜力。
Molecules. 2020 Jun 11;25(11):2707. doi: 10.3390/molecules25112707.
7
An approach for identification of novel inhibitors as potential therapeutics targeting COVID-19 main protease.针对新型冠状病毒主蛋白酶的潜在治疗靶点的新型抑制剂的鉴定方法。
J Biomol Struct Dyn. 2021 Aug;39(12):4304-4315. doi: 10.1080/07391102.2020.1776158. Epub 2020 Jun 16.
8
A search for medications to treat COVID-19 via in silico molecular docking models of the SARS-CoV-2 spike glycoprotein and 3CL protease.通过 SARS-CoV-2 刺突糖蛋白和 3CL 蛋白酶的计算机分子对接模型寻找治疗 COVID-19 的药物。
Travel Med Infect Dis. 2020 May-Jun;35:101646. doi: 10.1016/j.tmaid.2020.101646. Epub 2020 Apr 12.
9
Structure of M from SARS-CoV-2 and discovery of its inhibitors.SARS-CoV-2 M 结构与抑制剂的发现
Nature. 2020 Jun;582(7811):289-293. doi: 10.1038/s41586-020-2223-y. Epub 2020 Apr 9.
10
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.